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Background: Poststroke depression (PSD) is the most common and important neuropsychiatric 
consequences of stroke, which can result in longer hospital stay, compromise the effectiveness 
of rehabilitation, and reduce the patients’ quality of life. However, Iranian studies have reported 
different and conflicting prevalence rates for PSD.
Objective: The present systematic review and meta-analysis aimed to evaluate the overall 
prevalence of PSD in Iranian patients.
Patients and methods: A systematic search was conducted in 2018 for Persian or English 
articles on PSD, published in the Scientific Information Database (SID), MagIran, PubMed, 
Scopus, and Web of Science, using the following keywords: depression, depressive disorder, 
stroke, cerebrovascular disorder, and Iran and all of their possible combinations. Heterogeneity 
across the studies was evaluated using the Cochran’s Q test. According to the heterogeneity 
results, a random effects model was used to estimate the overall prevalence of PSD. The data 
were analyzed using the Stata 12 software.
Results: Overall, six articles with a total sample size of 641 patients were included in the 
analysis. The overall prevalence of PSD in Iran was 46.9% (95% CI: 30.1–63.7). In addition, 
the prevalence of PSD was higher in women (50.4%, 95% CI: 17.9–82.9) than in men (29.5%, 
95% CI: 17.2–41.8). According to the results of univariate meta-regression, there was a sig-
nificant relationship between PSD prevalence and sample size (P0.010).
Conclusion: Around half of the stroke patients in Iran suffer from PSD. Given the overlap 
between neurological symptoms of stroke and depression, efforts should be made to quickly 
and accurately diagnose depression so that it can be effectively managed with minimum 
complications.
Keywords: depression, stroke, outbreak, systematic review, meta-analysis, Iran
Introduction
Stroke is a chronic and debilitating disease with an estimated socioeconomic burden far 
greater than that of cardiovascular disease and cancer.1 Stroke occurs due to an abnor-
mality in the blood supply to the brain and is divided into two ischemic and hemorrhagic 
categories, according to the nature of the disorder.2 Annually, around 15 million people 
suffer from stroke worldwide, of whom about 5 million die and 5 million suffer from 
permanent disabilities.3 According to reports, 10% of patients with stroke and 25% 
of those suffering from minor complications are recovered. However, another 40% of 
stroke patients experience severe and serious complications and require special care, 
of whom 10% require permanent and lifelong care, whereas around 15% die shortly 
after stroke.4 Stroke is a very important incident in the patients’ lives and can lead to 
multiple psychosocial, social, and economic consequences, such as seizures, motor 
disorders, and psychiatric problems.5
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Although stroke can have unpredictable effects on each 
person, poststroke depression (PSD) is the most common and 
major neuropsychiatric consequence of stroke that affects 
one-third of survivors.6 The results of various meta-analyses 
have shown a positive and significant relationship between 
stroke and depression.7,8 At least one-third of stroke survivors 
exhibit mood and depression symptoms following the stroke.9 
Loss of energy, increase or decrease in the duration of sleep, 
restlessness, unconsciousness during activities, feeling use-
less, distraction, behavioral changes, and suicidal thoughts 
are among the common symptoms of PSD.10 Patients with 
PSD experience more functional disabilities, longer hospital 
stay, poorer rehabilitation results, lower quality of life, and 
high mortality in the first year after the stroke.10–12 The dis-
ease is often not diagnosed and left untreated.13,14 Several 
factors have been shown to predict PSD, including physical 
disability, severity of stroke, history of depression, and 
cognitive impairment.10,15,16
About 25%–79% of stroke survivors suffer from PSD. 
Different prevalence rates are partly due to the use of dif-
ferent diagnostic criteria and different assessment times.10 
A meta-analysis evaluating the prevalence of PSD reported 
by observational studies found a prevalence of 33%, whereas 
another meta-analysis examining the prevalence of mood 
disorders after stroke reported a prevalence of 17.7% for 
major depressive disorder and a prevalence of 13.1% for 
minor depressive disorder.17,18 Similarly, Iranian studies have 
reported conflicting prevalence rates for PSD, ranging from 
18% to 72.5%.19,20 Considering that any effort to prevent 
and treat depression in stroke patients requires accurate 
statistical data from the community, and given the lack of 
systematic studies focused on this issue in Iran, the present 
study is aimed at accurately estimating the prevalence of 
PSD in Iranian patients.
Participants and methods
This is a systematic review and meta-analysis of Iranian 
studies focused on the prevalence of PSD in Iran, published 
in the Iranian and international journals from inception until 
2018. In this study, articles published in the Iranian and 
international databases, including Scientific Information 
Database (SID), MagIran, PubMed, Scopus, and Web of Sci-
ence, were searched using the following keywords: depres-
sion, depressive disorder, stroke, cerebrovascular disorder, 
and Iran. For instance, the search strategy in the PubMed 
database was as follows: (“Depression”[All Fields] OR 
“depressive disorder”[All Fields]) AND ((“stroke”[MeSH 
Terms] OR “stroke”[All Fields]) OR “cerebrovascular 
disorder”[All Fields]) AND (“Iran”[MeSH Terms] 
OR “Iran”[All Fields]). The reference lists of the selected 
articles were also reviewed to find other related articles.
Study selection and data extraction
First, all the articles investigating the prevalence of depres-
sion in patients with stroke were chosen. The inclusion 
criteria were as follows: observational studies, published in 
Persian or English, and access to the full texts of articles. 
Nonrelated studies, case reports, letters to editors, interven-
tional studies, and repeated studies were excluded. To reduce 
bias, the search process, study selection, evaluation of the 
studies’ quality, and data extraction were conducted by two 
researchers independently. Disagreements between the two 
researchers were resolved through discussions. The following 
information was extracted from each article and recorded in 
an appropriate form: name of the first author, year of publica-
tion, place of publication, total sample size, sample size by 
gender, language of the study, diagnostic criteria, and pro-
portion of participants with depression and PSD by gender. 
Methodological quality was evaluated using a standard tool 
assessing the following five aspects of the studies: study plan, 
comparison groups, sample characteristics, sample size, and 
data collection tools; each item was rated on a scale from 
0 to 3. Total scores ranged from 0 to 15, with higher scores 
indicating higher methodological quality. Accordingly, the 
articles were divided into the following three categories: poor 
quality (scored 0–5), moderate (scored 6–10), and strong 
(scored above 10).21–24
Statistical analysis
For each selected study, a point estimate and a 95% CI for 
PSD prevalence were calculated based on the binomial dis-
tribution. Due to heterogeneity among the selected studies, 
data analysis was performed using the random effects model 
(Dersimonian and Laird). A forest plot was used to display 
the prevalence of PSD in the selected articles, based on 
effect size and 95% CI. The I2 index was used to examine 
the percentage of overall change due to heterogeneity. Based 
on the I2 index, heterogeneity level was classified into low 
heterogeneity (25%), moderate heterogeneity (25%–75%), 
and high heterogeneity (more than 75%).25 The univariate 
meta-regression was used to investigate the relationship of 
the prevalence of PSD with article’s year of publication and 
sample size. Using the subgroup analysis, the combined 
prevalence rate was estimated based on gender, screening 
criteria, and five regions of Iran. In addition, after assessing 
the publication bias and the effect of small sample sizes, 
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the funnel plot was used based on the Egger’s regression test. 
Data analysis was performed using the Stata 12 software.
Results
In this meta-analysis, the most recent articles published 
from 2007 to 2015 were reviewed. In the first step, a total 
of 615 articles were identified through the search process, 
of which a total of 604 articles were excluded based on 
the exclusion criteria. In the next step, the full-texts of the 
remaining 11 articles were analyzed. Among the 11 articles, 
five articles lacked adequate data for analysis and were dis-
carded. Finally, a total of six articles examining the preva-
lence of PSD in Iran were analyzed based on the PRISMA 
statement (Figure 1).26
The total sample size was 641, ranging from 40 to 205 
(M106). Four articles were in Persian, and two articles were 
in English. In terms of methodological quality, all the studies 
were of moderate quality (Table 1).
The overall prevalence of PSD in the Iranian patients 
was 46.9% (95% CI: 30.1–63.7). The overall prevalence 
of PSD was 29.5% (95% CI: 17.2–41.8) in men and 50.4% 
(95% CI: 17.9–82.9) in women. The findings based on screen-
ing tools showed that the prevalence of PSD was 53.2% (95% 
CI: 37.5–68.9) based on the Hospital Anxiety and Depres-
sion Scale (HADS) and Beck Depression Inventory (BDI) 
and 40.4% (95% CI: 13.3–67.4) based on the Diagnostic 
and Statistical Manual of Mental Disorders, fourth edition 
(DSM-IV). The prevalence of PSD reported by the studies 
conducted in region 5 (50.5%, 95% CI: 33.8–67.1) was 
higher than that reported by the studies conducted in region 
1 (45.2%, 95% CI: 22.2–68.2) (Figures 2 and 3).
According to the meta-regression results, there was no 
significant relationship between PSD prevalence and article’s 
year of publication, but PSD prevalence significantly reduced 
with an increase in sample size (Figure 4).
The findings indicated that the publication bias in the 
present study was significant (P0.005) (Figure 5).
Discussion
The aim of this study was to estimate the overall prevalence 
of PSD in Iranian patients. A total of six qualified articles 
were examined. Among these, four articles had reported 
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similar prevalence rates. The lowest (18%) and the highest 
(72%) prevalence rates were in Ahangar and Hosseini19 and 
Haghgoo et al,20 respectively. The highest prevalence of  PSD 
had been reported by Haghgoo et al. In their study, 65.5% of 
the patients were completely or partially dependent on others 
in performing the activity of daily living (ADL) and did not 
have independence in everyday tasks. It seems logical that 
losing independence can lead to depression. In the study by 
Ahangar and Hosseini also, no clear reason had been reported 
for the low prevalence of depression.
The results showed that nearly half of the patients with 
stroke suffered from depression. This rate is higher than those 
reported in USA (31%) and New Zealand (23%).31,32 A meta-
analysis study by Hackett et al17 showed that the prevalence 
of PSD (at any time after stroke) was 33%. In the study by 
Ariful Islam et al,33 70% of the patients in Bangladesh had 
depression symptoms. Various studies have led to different 
results. This variation could be attributed to the demographic 
characteristics of the countries in which the studies were 
conducted and the use of different measurement instruments. 
Wolfe believes that measuring depression in patients with 
stroke is a unique challenge, since many stroke-related neu-
rological symptoms, such as energy loss, fatigue, restless-
ness, sleep disturbances, and concentration problems, can 
have symptoms similar to those of depression. The patients 
may also have multiple neuropsychiatric disorders, making 
neuropsychiatric assessments more challenging.1 PSD is a 
stressful response to experiencing stroke, especially when 
the patient is faced with the negative outcomes of the illness; 
some also attribute it to early organic dysthymia, which is due 
Table 1 Characteristics of the six selected articles
Prevalence 
rate
Instrument Region Language Place Sample size 
(male/female)
Year of 
publication
First author
45 DSM-IV 1 Persian Ramsar 80 (Ns/Ns) 2016 Ebrahimi-Rad27
47.4 HADS 1 Persian Sari 116 (57/59) 2014 Hassanzadeh28
72.5 BDI 1 English Tehran 40 (21/19) 2013 Haghgoo20
59 DSM-IV 5 Persian Rafsanjan 100 (35/65) 2012 Iranmanesh29
18 DSM-IV 1 English Babol 205 (97/108) 2009 Ahangar19
42 BDI 5 Persian Zahedan 100 (61/39) 2008 Lashkaripour30
Abbreviations: BDI, Beck Depression Inventory; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HADS, Hospital Anxiety and Depression Scale; 
Ns, not stated.
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Figure 2 Forest plot of the prevalence of poststroke depression in Iranian patients.
Notes: The 95% CI for each study is shown in the form of horizontal lines around the central mean, the midpoint of the dotted line represents the mean of the overall score, 
and the lozenge shape shows the CI of the prevalence of this disorder. Weights are from random-effects analysis.
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to neurobiological changes during stroke.34 Heterogeneity 
across the studies can be due to different populations and 
difference in the study design, using different assessment 
methods, small sample sizes, and definitions for the variables. 
The articles reviewed in our meta-analysis had different 
sample sizes and assessment tools. In our meta-analysis, 
there was a high level of heterogeneity across the studies 
that could be due to clinical or methodological differences. 
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Figure 3 Forest plot of the prevalence of poststroke depression based on gender.
Note: Weights are from random-effects analysis.
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This heterogeneity could influence the estimation of the 
combined effect size for stroke; therefore, the findings should 
be interpreted with caution.
In this study, the prevalence of PSD in women was higher 
than that in men (50.4 vs 29.5%), which was consistent 
with the results of the studies conducted in Bangladesh and 
China.33,35 A systematic review study with 47 selected studies 
aimed at assessing the prevalence of PSD in men and women 
showed that, in 35 studies, there was a higher prevalence of 
PSD in women than in men.36 According to the WHO, fol-
lowing stroke, women tend to be hospitalized longer than 
men and are less likely to use rehabilitation programs. As a 
result, they become more disabled than men, which could be a 
potential reason for the higher prevalence of PSD in women. 
Other causes, such as genetic and social factors, age, cogni-
tive impairment, and access to rehabilitation programs, may 
also play a role in the higher prevalence of PSD in women.37 
It should also be noted that the prevalence of PSD in many 
studies is based on a single type of stroke; therefore, more 
precise studies are needed on the relationship between gender 
and PSD prevalence in different types of stroke.
Considering that, so far, few studies have been conducted 
on the prevalence of PSD in Iran and that the earliest meta-
analysis on this topic in Iran dates back to 2007, we can 
argue that this group of patients in Iran has not received 
enough attention regarding their psychological needs after 
treatment. Despite the high level of heterogeneity in the 
present meta-analysis, the high prevalence of PSD in Iran 
was expected, considering the limited studies on this topic 
and not paying enough attention to depressive symptoms in 
this group of patients.
The meta-regression findings showed an increase in the 
prevalence of PSD at this time but were not statistically 
significant. Other studies have examined changes in PSD 
over a short period of time and reported different findings. 
In the study by Verdelho et al,38 the prevalence of PSD in 
the first 6 months after stroke was 43%; this was reduced to 
18% in the third year after the disease. However, in another 
study, in the first year after stroke, the prevalence of PSD 
was 16%, but in the third year after stroke, it was increased 
to 29%.39 In our meta-analysis, meta-regression was used 
to identify the source of heterogeneity among the following 
two predetermined covariates: article’s year of publication 
and sample size; the results indicated that different sample 
sizes were the source of high heterogeneity.
The prevalence rates of PSD in the studies conducted in 
the region 1 were lower than those in the studies conducted 
in region 5. The reason for the difference is that region 1 
includes Tehran (the capital of Iran) and neighboring cities. 
Therefore, the patients in this region have better access to 
health care facilities; therefore, they are more easily and 
quickly identified and treated. PSD is a multifactorial phe-
nomenon that is influenced by many factors. Among the six 
reviewed articles, four articles had been conducted in region 1 
of Iran. Iran’s region 1 includes Tehran (Iran’s capital) and 
the adjacent cities, which have almost similar populations 
in terms of cultural, ethnic, and religious characteristics. 
Therefore, we can be pretty much sure that the cultural, 
ethnic, and religious effects were adjusted. Publication bias 
was significant in our meta-analysis, perhaps because articles 
with negative or insignificant results were not published, or 
even because the sponsors of the studies did not approve 
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Figure 5 Publication bias.
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their results. Articles written in English are usually of better 
methodological quality (blinding, random allocation, and 
adequate sample sizes) compared to the studies written in 
other languages. In addition, studies with significant results 
are more likely to be published in the top-ranked journals.
In the present meta-analysis, for the first time, the Iranian 
studies on the prevalence of PSD were systematically 
reviewed and analyzed; this can be regarded as strength of 
it. However, lack of access to sufficient information, such as 
type of stroke (hemorrhagic or thromboembolic), location of 
the lesion (right or left), and the overall score on the disability 
index were some of the limitations of the study that prevented 
us from conducting a more comprehensive analysis.
Conclusion
The study findings showed that nearly half of the Iranian 
stroke patients suffered from PSD. Depression leads to 
reduced treatment adherence and ultimately worsens the 
patient’s condition. Given the overlap between neurological 
and depressive symptoms and the presence of several neu-
rological disorders in the stroke patients, developing a good 
understanding of PSD is important in controlling the illness 
and providing the required interventions for the patients.
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